Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Treatment of Complicated UTI in Female Adult with ESBL E. coli and Nephrostomy

Understanding the Condition

  • The presence of ESBL-producing organisms is a factor associated with complicated UTIs, according to the European Urology guidelines 1
  • Complicated UTIs are defined as infections occurring in patients with underlying structural or medical problems, including foreign bodies, urinary tract obstruction, and indwelling catheters 3
  • The case represents a complicated UTI due to both the presence of ESBL-producing E. coli and the nephrostomy tube, which is considered a foreign body and structural abnormality of the urinary tract 1, 2

Initial Assessment and Management

  • Obtain urine culture and susceptibility testing before initiating antimicrobial therapy to guide targeted treatment, as recommended by the European Urology guidelines 1, 4
  • Assess severity of illness and hemodynamic stability to determine if inpatient or outpatient management is appropriate 1
  • Management of the underlying urological abnormality, such as ensuring proper nephrostomy function, is mandatory alongside antimicrobial therapy 1

Antimicrobial Treatment Options

  • Carbapenems, such as meropenem, are considered highly effective against ESBL-producing organisms, with a recommended dosage of 1g three times daily 1
  • The European Urology guidelines recommend treatment for 7-14 days for complicated UTIs 1, 2

Special Considerations

  • Avoid fluoroquinolones for empiric treatment due to increasing resistance rates, especially in ESBL-producing organisms 1
  • Consider removal or exchange of the nephrostomy tube if clinically indicated, as foreign bodies can serve as a nidus for persistent infection 1, 3
  • Monitor for clinical improvement within 48-72 hours of initiating appropriate antimicrobial therapy 1

Follow-up

  • Follow-up urine culture is not necessary if symptoms resolve completely, according to The Journal of Urology guidelines 5
  • Avoid surveillance urine testing in asymptomatic patients to prevent unnecessary treatment of asymptomatic bacteriuria 5